The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Celgene; Janssen; Karyopharm Therapeutics; Merck
Update of CARTITUDE-1: A phase Ib/II study of JNJ-4528, a B-cell maturation antigen (BCMA)-directed CAR-T-cell therapy, in relapsed/refractory multiple myeloma.
 
Jesus G. Berdeja
Consulting or Advisory Role - Amgen (Inst); BioClinica (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); crispr therapeutics (Inst); Janssen (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); Kite, a Gilead company (Inst); Legend Biotech (Inst); prothena (Inst); SERVIER (Inst); Takeda (Inst)
Research Funding - Abbvie (Inst); Acetylon Pharmaceuticals (Inst); Amgen (Inst); Bluebird Bio (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Constellation Pharmaceuticals (Inst); CURIS (Inst); Genentech/Roche (Inst); Glenmark (Inst); Janssen (Inst); Kesios Therapuetics (Inst); Lilly (Inst); Novartis (Inst); poseida therapeutics (Inst); Sanofi (Inst); Takeda (Inst); Teva (Inst); Vivolux (Inst)
 
Deepu Madduri
Consulting or Advisory Role - Abbvie; Celgene; Foundation Medicine; Janssen Research & Development; Takeda
 
Saad Zafar Usmani
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Seagen; Skyline Diagnostics; Takeda
Speakers' Bureau - Amgen; Celgene; Janssen Oncology; Takeda
Research Funding - Amgen; Array BioPharma; Bristol-Myers Squibb; Celgene; Janssen Oncology; Pharmacyclics; Sanofi; Seagen
 
Indrajeet Singh
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Enrique Zudaire
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Tzu-Min Yeh
Employment - Janssen
Stock and Other Ownership Interests - Johnson & Johnson
 
Alicia J. Allred
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Yunsi Olyslager
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Arnob Banerjee
No Relationships to Disclose
 
Jenna D. Goldberg
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Jordan Schecter
No Relationships to Disclose
 
Dong Geng
Employment - Legend Biotech
Stock and Other Ownership Interests - Legend Biotech
Travel, Accommodations, Expenses - Legend Biotech
Other Relationship - Legend Biotech
 
Xiaoling Wu
Employment - Legend Biotech
Stock and Other Ownership Interests - Legend Biotech
 
Marlene Carrasco-Alfonso
Employment - Legend Biotech; Novartis Pharmaceuticals UK Ltd.
Stock and Other Ownership Interests - Abeona Therapeutics (I); Adaptimmune (I); Adverum (I); Akcea Therapeutics (I); Allogene Therapeutics (I); Alnylam (I); Arbutus Biopharma (I); Arrowhead Pharmaceuticals (I); Atara Biotherapeutics (I); Audentes Therapeutics (I); Bellicum Pharmaceuticals (I); Biomarin (I); Bluebird Bio (I); Cellectis (I); crispr therapeutics (I); Editas Medicine (I); Fate Therapeutics (I); Intellia Therapeutics (I); Ions Pharmaceuticals (I); Iovance Biotherapeutics (I); Juno Therapeutics (I); Kite, a Gilead company (I); Legend Biotech; Moderna Therapeutics (I); Neon Therapeutics (I); Novartis; REGENXBIO (I); Sangamo Therapeutics (I); Sarepta Therapeutics (I); Sorrento Therapeutics (I); Spark Therapeutics (I); Ultragenyx Pharmaceuticals (I); Uniqure (I); Verastem (I); Voyager Therapeutics (I); ZIOPHARM Oncology (I)
 
Syed Rizvi
Employment - Legend Biotech
Leadership - Legend Biotech
Stock and Other Ownership Interests - Legend Biotech
Travel, Accommodations, Expenses - Legend Biotech
 
Frank (Xiaohu) Fan
Employment - Legend Biotech
Leadership - Legend Biotech
Stock and Other Ownership Interests - Legend Biotech
Patents, Royalties, Other Intellectual Property - Legend Biotech
 
Andrzej J. Jakubowiak
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Millennium; Sanofi; Skyline Diagnostics; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Millennium; Sanofi; Skyline Diagnostics; Takeda
 
Sundar Jagannath
No Relationships to Disclose